We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Efficacy of Intravesical Instillation Therapy with Low-Dose Tokyo-172 Bacillus Calmette-Guérin to Prevent Recurrence of Non-Muscle-Invasive Bladder Cancer and Treat Carcinoma in situ: A Multi-Institutional Retrospective Study
Urol. Int. 2023 Jan 16;[EPub Ahead of Print], T Tachibana, M Ikeda, S Shimura, N Amano, Y Murakami, Y Yamada, D Koguchi, R Maeyama, M Kawamura, Y Sakata, M Hagiwara, K Matsumoto, M Iwamura